Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Patients With Postherpetic Neuralgia
This study is ongoing, but not recruiting participants.
Sponsor:
Cubist Pharmaceuticals
Collaborator:
Pfizer
Information provided by:
Cubist Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01058642
First received: January 27, 2010
Last updated: June 6, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2011 |
| Estimated Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |